Fund Name | Location |
Airbridge Equity Partners | Amsterdam, Noord-Holland, The Netherlands |
Amylin Pharmaceuticals | California, San Diego, United States |
Archipelago Advisa Investment | Indonesia, Jawa Tengah, Surakarta |
Arizona Tech Investors | Arizona, Mesa, United States |
Bank of Hangzhou | China, Hangzhou, Zhejiang |
Economic Development of the Longueuil Conurbation | Boucherville, Canada, Quebec |
Franklin Square Group | District of Columbia, United States, Washington |
Jayant Group | Bilaspur, Chhattisgarh, India |
Manipal Hospitals | Bangalore, India, Karnataka |
MI8 | - |
Mogo | British Columbia, Canada, Vancouver |
NY Group Partners | - |
Parco | Japan, Toshima |
Point72 Ventures | New York, New York, United States |
Prestige Angel | Beijing, Beijing, China |
Times Bridge | California, Redwood City, United States |
Wille Finance | Switzerland, Zürich, Zurich |
Willfly Ventures | India, Maharashtra, Mumbai |
Wiretap Ventures | Colorado, Denver, United States |
Xidihui Zichan | China, Fujian, Xiamen |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.